Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity

Ähnliche Einträge

• Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy
  von: Qian Yin, et al.
  Veröffentlicht: (2024)
• Modified Hongteng Baijiang decoction enema improves sequelae of pelvic inflammatory disease by regulating the LIF/JAK2/STAT3 pathway and gut microbiota
  von: Xiaoli Ji, et al.
  Veröffentlicht: (2024)
• Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis
  von: Luping Chen, et al.
  Veröffentlicht: (2024)
• Rat nasal mucosa‐derived ectodermal mesenchymal stem cells: A new therapeutic option for chronic rhinosinusitis
  von: Liujin Li, et al.
  Veröffentlicht: (2024)
• MiR‐9‐enriched mesenchymal stem cells derived exosomes prevent cystitis‐induced bladder pain via suppressing TLR4/NLRP3 pathway in interstitial cystitis mice
  von: Xiangrong Cui, et al.
  Veröffentlicht: (2024)